α-淀粉酶抑制剂（白芸豆提取物）对2型糖尿病改善效果研究

In this study, α-Amylase inhibitor was introduced into the diet nutrition intervention of type 2 diabetic patients to study its effect on the glycometabolism index of type 2 diabetes, so as to provide a more simple and effective scheme for the nutrition intervention of diabetes. 90 patients with type 2 diabetes were divided into two groups: the experimental group (comprehensive diet nutrition intervention group) and the control group (general diet nutrition intervention group) (the actual number of the experimental group is 63, the actual number of the control group is 27). The nutrition intervention experiment lasted for 18 weeks. The experimental group was given α - AI of white kidney bean before each meal, the control group was given the same dose of maltodextrin, and the other two groups were given the same intervention. Blood glucose was monitored regularly in all subjects. The results showed that the average hemoglobin, fasting blood glucose and postprandial blood glucose decreased significantly in the experimental group, and the decrease was significantly greater than that in the control group. The decrease of LDL in the experimental group was significantly larger than that in the control group, and the increase of HDL in the experimental group was significantly larger than that in the control group. After intervention, there were no significant changes in hemoglobin, BMI and uric acid levels in the experimental group and the control group. White kidney bean α - AI can regulate the blood glucose and blood lipid of type 2 diabetic patients, improve the vascular complications of diabetic patients, and is expected to become a new type of health food regulating blood glucose and blood lipid.